N-(2-nitro-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide | 104509-10-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-(2-nitro-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide
• 英文别名: 1-(Acetylamino)-2-nitro-5,6,7,8-tetrahydronaphtalene
• CAS: 104509-10-6
• 化学式: C₁₂H₁₄N₂O₃
• 分子量: 234.255
• InChiKey: QWMFLYBAEHSFLC-UHFFFAOYSA-N

物化性质

• 沸点：
  437.0±45.0 °C(Predicted)
• 密度：
  1.292±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  74.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(2-nitro-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide 在 盐酸 、 sodium hydroxide 、 锌 作用下， 以 乙醇 为溶剂， 反应 15.75h， 生成 5,6,7,8-四氢-1,2-萘二胺
  参考文献：
  名称：

  [EN] POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION
  [FR] COMPOSÉ POLYCYCLIQUE ET DISPOSITIF ÉLECTROLUMINESCENT ORGANIQUE COMPRENANT LE COMPOSÉ POLYCYCLIQUE OU UNE COMPOSITION

  摘要：

  特定的多环化合物，一种含有该特定多环化合物的有机电致发光装置材料，一种含有该特定多环化合物的有机电致发光装置，一种包含该有机电致发光装置的电子设备，一种制备所述多环化合物的方法，以及所述多环化合物在有机电致发光中的用途。（公式 I）(I)

  公开号：

  WO2020217229A1
• 作为产物：
  描述：

  萘酚 在 硫酸 、 硝酸 、 镍 作用下， 生成 N-(2-nitro-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide
  参考文献：
  名称：

  Schroeter, Justus Liebigs Annalen der Chemie, 1922, vol. 426, p. 132

  摘要：

  DOI：

文献信息

• [EN] THERAPEUTIC B7-H4 BINDING MOLECULES<br/>[FR] MOLÉCULES THÉRAPEUTIQUES SE LIANT À B7-H4
  申请人：MEDIMMUNE LTD

  公开号：WO2022053650A1

  公开（公告）日：2022-03-17

  The present invention relates to binding molecules (e.g. antibodies) for the treatment of cancer, and related antibody-drug conjugates.

  本发明涉及用于治疗癌症的结合分子（例如抗体）以及相关的抗体药物结合物。
• Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
  申请人：——

  公开号：US20020055526A1

  公开（公告）日：2002-05-09

  The present invention relates to ion channel modulating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as modulators of SK Ca , IK Ca and BK Ca channels. In further aspects, the present invention relates to the use of these SK/IK/BK channel modulating agents for the manufacture of medicaments, and pharmaceutical compositions comprising the SK/IK/BK channel modulating agents. The SK/IK/BK channel modulating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK/BK channels.

  本发明涉及离子通道调节剂。更具体地，本发明涉及一类特定的化合物，已被证明可作为SKCa、IKCa和BKCa通道的调节剂。此外，本发明还涉及利用这些SK/IK/BK通道调节剂制造药物，并包括这些SK/IK/BK通道调节剂的药物组合物。本发明的SK/IK/BK通道调节剂可用于治疗或缓解与SK/IK/BK通道相关的疾病和症状。
• [EN] COMPOUNDS AND CONJUGATES THEREOF<br/>[FR] COMPOSÉS ET CONJUGUÉS CORRESPONDANTS
  申请人：MEDIMMUNE LTD

  公开号：WO2021148500A1

  公开（公告）日：2021-07-29

  A conjugate comprising the following topoisomerase inhibitor derivative (A*): where Y is H or F, with a single overall linker moiety connecting two topoisomerase inhibitor derivatives to a Ligand Unit, wherein the topoisomerase inhibitor derivatives are cleavable from the Ligand Unit. Also provided is A* with the linking unit attached, and intermediates for their synthesis.

  一个包含以下拓扑异构酶抑制剂衍生物（A*）的共轭物：其中Y为H或F，具有将两个拓扑异构酶抑制剂衍生物连接到配体单元的单一整体连接基团，其中拓扑异构酶抑制剂衍生物可以从配体单元中解离。还提供了附有连接单元的A*，以及它们合成的中间体。
• [EN] NEW BENZIMIDAZOLONE-, BENZOXAZOLONE-, OR BENZOTHIAZOLONE DERIVATIVES AS ION CHANNEL MODULATING AGENTS<br/>[FR] NOUVEAUX DERIVES DE BENZIMIDAZOLONE, DE BENZOXAZOLONE OU DE BENZOTHIAZOLONE AGISSANT COMME AGENTS DE MODULATION DE CANAUX IONIQUES
  申请人：NEUROSEARCH AS

  公开号：WO2000034248A1

  公开（公告）日：2000-06-15

  The present invention relates to ion channel modulating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as modulators of SKCa, IKCa and BKCa channels. In further aspects, the present invention relates to the use of these SK/IK/BK channel modulating agents for the manufacture of medicaments, and pharmaceutical compositions comprising the SK/IK/BK channel modulating agents. The SK/IK/BK channel modulating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK/BK channels.

  本发明涉及离子通道调节剂。更具体地，本发明涉及一类已被证明可用作SKCa、IKCa和BKCa通道调节剂的化学化合物。在进一步的方面，本发明涉及使用这些SK/IK/BK通道调节剂制造药物，以及包含SK/IK/BK通道调节剂的制药组合物。本发明的SK/IK/BK通道调节剂可用于治疗或缓解与SK/IK/BK通道相关的疾病和症状。
• Ion channel modulating agents comprising novel benzimidazolone derivatives
  申请人：Neurosearch A/S

  公开号：US06624186B2

  公开（公告）日：2003-09-23

  The present invention relates to ion channel modulating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as modulators of SKCa, IKCa and BKCa channels. In further aspects, the present invention relates to the use of these SK/IK/BK channel modulating agents for the manufacture of medicaments, and pharmaceutical compositions comprising the SK/IK/BK channel modulating agents. The SK/IK/BK channel modulating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK/BK channels.

  本发明涉及离子通道调节剂。更具体地，本发明涉及一类已被证明可作为SKCa、IKCa和BKCa通道调节剂的化合物。在进一步的方面，本发明涉及使用这些SK/IK/BK通道调节剂制造药物，以及包括SK/IK/BK通道调节剂的制药组合物。本发明的SK/IK/BK通道调节剂对于治疗或缓解与SK/IK/BK通道相关的疾病和症状是有用的。